Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “treatment”

2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,520
Index total 30,257
Page 71 / 105

Quick answer

This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,520 results for “treatment” · 30,257 patents in full index Clear search

  1. US 8999934

    Treatment of astrocytes-tumor cells inhibitors of endothelin receptors

    The Board of Regents of the University of Texas System · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  2. US 8999638

    Method of treatment based on polymorphisms of the KCNQ1 gene

    VANDA PHARMACEUTICALS INC. · Granted Apr 7, 2015 · Expires Apr 2, 2035

    granted

  3. US 8993627

    N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress

    SENTIENT LIFESCIENCES, INC. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  4. US 8993552

    Compositions and methods for treatment of leukemia

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  5. US 8993633

    Treatment of muscle disease characterized by insulin resistance

    Fate Therapeutics, (Canada) Inc. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  6. US 8993519

    Method of treatment for neutropenia using stable formulations of recombinant human albumin-human granulocyte colony stimulating factor

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  7. US 8993626

    Methods of treatment using sterculic acid

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 31, 2015 · Expires Mar 26, 2035

    granted

  8. US 8987308

    Compounds for the treatment of Clostridium difficile-associated disease

    Summit Corporation Plc · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  9. US 8987228

    Pharmaceutical composition including an A3 adenosine receptor agonist 1-deooxy-1-[N6-(3-idobenzyl)-adenin-9-yl]-N-methyl-β-D-ribofuronamide(IB-MECA/CF-101) for treatment of psoriasis

    CAN-FITE BIOPHARMA LTD. · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  10. US 8986737

    Antibiotic microspheres for treatment and prevention of osteomyelitis and enhancement of bone regrowth

    The Board of Regents of the University of Texas System · Granted Mar 24, 2015 · Expires Mar 19, 2035

    granted

  11. US 8980871

    Methods of treatment for hemolysis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  12. US 8980549

    MicroRNA patterns for the diagnosis, prognosis and treatment of melanoma

    TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD. · Granted Mar 17, 2015 · Expires Mar 12, 2035

    granted

  13. US 8974363

    Topical medicaments and methods for photodynamic treatment of disease

    Provectus Pharmatech, Inc. · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted

  14. US 8975243

    Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract

    The Regents of the University of California · Granted Mar 10, 2015 · Expires Mar 5, 2035

    granted

  15. US 8969409

    Treatment for pulmonary hypertension

    United Therapeutics Corporation · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  16. US 8968729

    Date pit composition for the treatment of animals

    UNITED ARAB EMIRATES UNIVERSITY · Granted Mar 3, 2015 · Expires Feb 26, 2035

    granted

  17. US 8962593

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  18. US 8962824

    Composition of novel carbohydrate drug for treatment of human diseases

    GALECTIN THERAPEUTICS, INC. · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  19. US 8962561

    Compositions comprising PEDF and uses of same in the treatment and prevention of ovary-related syndromes

    The Fund for Medical Research, Development of Infrastructure and Health Services—Assaf HaRofeh Medical Center · Granted Feb 24, 2015 · Expires Feb 19, 2035

    granted

  20. US 8957047

    GLA monotherapy for use in cancer treatment

    IMMUNE DESIGN CORP. · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  21. US 8956616

    Constructs binding to phosphatidylserine and their use in disease treatment

    The Board of Regents of the University of Texas System · Granted Feb 17, 2015 · Expires Feb 12, 2035

    granted

  22. US 8952062

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Jazz Pharmaceuticals, Inc. · Granted Feb 10, 2015 · Expires Feb 5, 2035

    granted

  23. US 8946409

    Polycyclic β lactam derivatives for the treatment of cancer

    The Board of Regents of the University of Texas System · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

  24. US 8946158

    Treatments of gastrointestinal disorders

    IRONWOOD PHARMACEUTICALS, INC. · Granted Feb 3, 2015 · Expires Jan 29, 2035

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.